Percutaneous left ventricular assist device in acute myocardial infarction and cardiogenic shock

William Merhi1, Simon R Dixon, William W O'Neill

  • 1Department of Medicine, Cardiology Division, William Beaumont Hospital, Royal Oak, Michigan, USA.

Insights

This case review highlights a novel approach for managing cardiogenic shock following non-ST elevation myocardial infarction (MI). A percutaneous left atrial-to-femoral arterial ventricular assist device showed potential therapeutic utility in a complex MI patient.

Area of Science:

  • Cardiology
  • Cardiovascular Interventions
  • Critical Care Medicine

Background:

  • Acute myocardial infarction (MI) remains a leading cause of mortality worldwide.
  • Cardiogenic shock (CS) complicating MI carries a high mortality rate despite advances in percutaneous coronary intervention.
  • Non-ST segment elevation MI (NSTEMI) can also present with or precipitate CS, posing significant management challenges.

Observation:

  • This case review details the management of a patient with NSTEMI complicated by CS.
  • The patient's clinical course and the therapeutic interventions employed are described.
  • Particular focus is placed on the utilization of a specific mechanical circulatory support device.

Findings:

  • The case demonstrates the application of a percutaneous left atrial-to-femoral arterial ventricular assist device (LA-FA VAD) in a patient with NSTEMI and CS.
  • The clinical and therapeutic utility of this LA-FA VAD in supporting the patient during this critical phase is discussed.
  • Successful implementation of the device was observed in managing the hemodynamic instability.

Implications:

  • This case suggests that LA-FA VADs may be a viable option for mechanical circulatory support in select patients with CS due to NSTEMI.
  • Further research is warranted to establish the broader efficacy and safety of LA-FA VADs in CS management.
  • This approach could potentially improve outcomes for high-risk MI patients experiencing cardiogenic shock.